Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA.
| Revenue (Most Recent Fiscal Year) | $0.09M |
| Net Income (Most Recent Fiscal Year) | $-68.69M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1000.61 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 14.60 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -148511.67% |
| Net Margin (Trailing 12 Months) | -73864.52% |
| Return on Equity (Trailing 12 Months) | -228.66% |
| Return on Assets (Trailing 12 Months) | -76.74% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.50 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.50 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 4.61 |
| Inventory Turnover (Trailing 12 Months) | 0.59 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.13 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.49 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.03 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.85 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 48.98M |
| Free Float | -- |
| Market Capitalization | $93.06M |
| Average Volume (Last 20 Days) | 0.24M |
| Beta (Past 60 Months) | 0.10 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |